SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LEXG-Lexicon Genetics -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (224)2/19/2010 2:24:18 PM
From: Arthur Radley  Read Replies (1) | Respond to of 254
 
News today from CEO that they have been contacted by big pharma for their RA drug is encouraging. Buying LXRX stock is like buying an option.......long term these guys might finally be getting their act down to some good science.



To: nigel bates who wrote (224)4/9/2010 1:12:10 PM
From: tuck  Respond to of 254
 
"Synthesis and SAR of Benzisothiazole- and Indolizine-ß-d-glucopyranoside Inhibitors of SGLT2"

Competition from Glaxo . . .

pubs.acs.org

Full text freebie.

Cheers, Tuck